Advertisement
BD Biosciences
BD Biosciences

Most Recent

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: Microbial Diversity

Microbial Diversity

By | July 14, 2013

By sequencing bacterial and archaeal genomes from single cells, scientists have filled in many uncharted branches of the tree of life.

2 Comments

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Gut Microbes for Life

Gut Microbes for Life

By | July 4, 2013

Most strains of gut microbes stay with us for decades, which may prove useful for tracking our health.

6 Comments

image: Foot Fungus Revealed

Foot Fungus Revealed

By | July 2, 2013

A new study profiles the garden of fungal organism that grows on human feet.

1 Comment

image: Crowd Control

Crowd Control

By | July 1, 2013

Molecules, cells, or vertebrates—when individuals move and act as a single unit, surprisingly complex behaviors arise that hint at the origins of multicellularity.

7 Comments

image: Image of the Day: <em>E. coli</em> Hunter

Image of the Day: E. coli Hunter

By | June 27, 2013

The Shiga toxin may help E. coli survive predation by the protist Tetrahymena.

0 Comments

image: Week in Review, June 17–21

Week in Review, June 17–21

By | June 21, 2013

On the gene patent decision; a high-res human brain model; bats’ influence on moths mating calls; toxicants threaten brain health; platelet-driven immunity

0 Comments

image: Nailing Regeneration

Nailing Regeneration

By | June 12, 2013

Researchers identify the signaling program that enables finger and toenail stem cells to direct digit regeneration after amputation.

0 Comments

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

Popular Now

  1. Turning Tumor Cells Against Cancer
  2. Neanderthals’ Genetic Legacy
  3. Brazil’s Pre-Zika Microcephaly Cases
    The Nutshell Brazil’s Pre-Zika Microcephaly Cases

    A review of four years’ worth of medical records finds far greater numbers of microcephaly cases from before the ongoing Zika virus epidemic than had been officially reported.

  4. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

Advertisement
Bertin Technologies
Bertin Technologies
Advertisement
Life Technologies